Best Case
15%Poultry controls improve quickly. Clinicians find cases earlier. Human infections remain rare and isolated.
Cambodia's H5N1 pattern is likely to remain sporadic: more human cases will appear, but sustained human-to-human spread is still unlikely. Better surveillance should find cases earlier, yet poultry exposure will keep producing occasional severe infections. The main risk is repeated zoonotic spillovers, not a near-term pandemic jump.
Verdict: WHO's March 13 update said no new human H5N1 cases were reported that week and that the last Cambodian case had onset on February 5, while WHO also says sporadic human cases are expected and sustained human spread is unlikely. CDC's March 20 Cambodia paper found 63% of recent cases were detected through SARI surveillance or testing close contacts, which implies surveillance gaps still matter (WHO, 2026-03-13; CDC, 2026-03-20; Xinhua, 2026-02-14). The most likely path is continued village-level spillovers, better case finding, and no pandemic shift in the next year.
Poultry controls improve quickly. Clinicians find cases earlier. Human infections remain rare and isolated.
A few more human cases appear each season. Most come from poultry exposure. No sustained human transmission emerges.
Animal outbreaks intensify and spillovers rise. Diagnosis still arrives late in some districts. Small household clusters become more common.
A new viral change raises concern. Limited human-to-human spread appears before being contained. Regional alarm rises even if a pandemic does not follow.
Developments: A few new human cases likely appear. Surveillance finds more of them sooner. Poultry exposure remains the main trigger.
Risks: Diagnosis can still come late. Village outbreaks can cluster. Cross-border animal movement complicates control.
Outlook: The pattern stays sporadic. Human spread remains unlikely. Public health focus stays on farms and households.
Developments: SARI surveillance expands. Clinician awareness improves. More contacts receive antivirals earlier.
Risks: Private clinics can miss cases. Backyard poultry remains common. Data gaps still hide infections.
Outlook: Case finding improves faster than prevention. Spillovers continue at a low level. The signal is better than the noise.
Developments: Outbreak response becomes more practiced. Contact tracing is faster. More local workers know the warning signs.
Risks: Control costs stay high. Animal outbreaks can still seed human cases. Underreporting remains possible.
Outlook: The country handles cases more smoothly. The case count may still rise in bad years. The risk stays zoonotic, not pandemic.
Developments: Better poultry health measures reduce exposure. Human cases still occur, but less often. Vaccination or prophylaxis tools may improve response.
Risks: Implementation is uneven in rural areas. Seasonal or market shocks can reverse gains. Global avian flu evolution stays uncertain.
Outlook: The average year looks safer. Exceptions still happen. Prevention matters more than treatment.
Developments: Animal surveillance and reporting become more routine. Human clusters are smaller. Outbreak response is faster than today.
Risks: New clades can slip through. Trade and farming patterns can reintroduce risk. Human vigilance can fade between events.
Outlook: H5N1 remains a recurring zoonotic problem. Large human outbreaks are still unlikely. The system is better at containment than eradication.
Developments: Biosecurity and surveillance likely improve substantially. Human cases become rarer. Response systems are more automated.
Risks: Wild bird reservoirs remain hard to control. New influenza reassortments can surprise authorities. Rural exposures never fully disappear.
Outlook: The baseline is fewer spillovers. The disease is managed, not eliminated. Preparedness stays necessary.
Developments: Future animal vaccines and monitoring may cut spillovers. Human cases become rare but still expected. International reporting is faster and more integrated.
Risks: Bird reservoirs can persist for decades. Evolution can create new surprises. Weak health systems remain vulnerable.
Outlook: The long-run risk is lower than today. The virus does not vanish from the planet. Monitoring remains a permanent task.